Coenzyme A trilithium salt, 95%
Coenzyme A trilithium salt, 95%
Coenzyme A trilithium salt, 95%
Thermo Scientific Chemicals

Coenzyme A trilithium salt, 95%

CAS: 18439-24-2 | C21H33Li3N7O16P3S | 785.329 g/mol
Have Questions?
Catalog NumberQuantity
J65434.MC
also known as J65434-MC
100 mg
Catalog number J65434.MC
also known as J65434-MC
Price (EUR)
247,65
Online Exclusive
275,00
Save 27,35 (10%)
Each
Quantity:
100 mg
Request bulk or custom format
Price (EUR)
247,65
Online Exclusive
275,00
Save 27,35 (10%)
Each
Chemical Identifiers
CAS18439-24-2
IUPAC Nametrilithium(1+) (3R)-3-hydroxy-2,2-dimethyl-3-({2-[(2-sulfanylethyl)carbamoyl]ethyl}carbamoyl)propyl ({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3-(hydrogen phosphonatooxy)-4-hydroxyoxolan-2-yl]methyl phosphonato}oxy)phosphonate
Molecular FormulaC21H33Li3N7O16P3S
InChI KeyQSCBPHBAFBVXRK-FFKZSOHASA-K
SMILES[Li+].[Li+].[Li+].CC(C)(COP([O-])(=O)OP([O-])(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)([O-])=O)N1C=NC2=C(N)N=CN=C12)[C@@H](O)C(=O)NCCC(=O)NCCS
View more
SpecificationsSpecification SheetSpecification Sheet
Appearance (Color)Pale cream to pale yellow
Assay from Supplier's CofA≥94.0%
FormLyophilized powder
Coenzyme A facilitates removal of lipid peroxides by increasing mobilization of fatty acids, and promote repair of plasma membranes by activating phospholipid synthesis. CoA is involved in the mechanisms of a wide variety of enzymes.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
Coenzyme A facilitates removal of lipid peroxides by increasing mobilization of fatty acids, and promote repair of plasma membranes by activating phospholipid synthesis. CoA is involved in the mechanisms of a wide variety of enzymes
RUO – Research Use Only

General References:

  1. Mayer, J.H.; Tomlinson, D.R. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Diabetologia. 1983, 25, (5), 433-438.
  2. James D. Clark.; Stephen J. O'Keefe.; Jeremy R. Knowles. Malate synthase: proof of a stepwise Claisen condensation using the double-isotope fractionation test. Biochemistry. 1988, 27, (16), 5961-5971.